Tetralogy of fallot MRI
Jump to navigation
Jump to search
Tetralogy of fallot Microchapters |
Diagnosis |
---|
Treatment |
|
Tetralogy of fallot MRI On the Web |
American Roentgen Ray Society Images of Tetralogy of fallot MRI |
Risk calculators and risk factors for Tetralogy of fallot MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2], Keri Shafer, M.D. [3]; Kristin Feeney, B.S. [4]
Overview
Magnetic resonance imaging can be helpful as a diagnostic tool in patients in whom the echocardiographic findings are inconclusive.
MRI
Advantages
- It can be used in cases where echocardiographic results are inconclusive.
- Assists in the measurement of heart volumes, blood flow and ventricular wall thickness.
- Magnetic resonance angiography can better visualize the heart vasculature.
- Phase velocity mapping helps in measuring the ratio of pulmonary to systemic blood flow (Qp:Qs).
Disadvantages
- For successful MRI procedure breath holding is required, which is sometimes difficult to achieve with small children. Due to this, the procedure may be performed under general anesthesia in children.
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[1]
Diagnostic Recommendations for Tetralogy of Fallot
Class I |
1.CMR is useful to quantify ventricular size and function, pulmonary valve function, pulmonary artery anatomy, and left heart abnormalities in patients with repaired TOF. (Level of Evidence: B-NR) |
2.Coronary artery compression testing is indicated before right ventricle–to-PA conduit stenting or transcatheter valve placement in repaired TOF. (Level of Evidence: B-NR) |
References
- ↑ Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM; et al. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". J Am Coll Cardiol. 73 (12): 1494–1563. doi:10.1016/j.jacc.2018.08.1028. PMID 30121240.